Mundipharma Philippines recently provided Povidone-Iodine products to the Bureau of Corrections as they partnered with the agency to promote oral and body hygiene among the inmates of the New Bilibid Prison in Muntinlupa.
As part of their corporate social responsibility program, the company gave Povidone-Iodine (Betadine) products in support of the Department of Health’s Knock-Out Tigdas drive.
This partnership with the BuCor, which was cemented through a turnover ceremony, will help more than 30,000 inmates attain better hygiene and physical health using Povidone-Iodine (Betadine) products.
Measles is regarded as a highly contagious and infectious condition. It can be transmitted by coughing or sneezing or through direct contact with anyone infected with it. Symptoms include high fever that lasts four to seven days, runny nose, cough, red and watery eyes, and white spots that develop inside the cheeks. After a few days, rashes appear and then it spreads all over the body.
Povidone-Iodine (Betadine) is clinically proven to effectively kill viruses, bacteria and fungi. The products from Mundipharma will help prevent the spread of contagious diseases such as flu and measles, as well as more common ailments like sore throat and mouth ulcers, and skin infections like boils, which may impact the well-being of the prisoners held in the facility.
“Mundipharma is invested in the well-being of every Filipino and this partnership with the BuCor is a testament to this dedication,” Ian Santos, Mundipharma Country Manager said.
“We believe that maintaining the health and well-being of the inmates housed within the New Bilibid Prison is an integral part of their rehabilitation,” he added.